The present and future panorama of dialysis

The current and future landscape of dialysis
December 8, 2020 0 Comments

  • 1.

    Peitzman, S. J. Continual dialysis and dialysis docs in the USA: a nephrologist-historian’s perspective. Semin. Dial. 14, 200–208 (2001).

    CAS 
    PubMed 

    Google Scholar 

  • 2.

    Brescia, M. J., Cimino, J. E., Appel, Ok. & Hurwich, B. J. Continual hemodialysis utilizing venipuncture and a surgically created arteriovenous fistula. N. Engl. J. Med. 275, 1089–1092 (1966).

    CAS 
    PubMed 

    Google Scholar 

  • 3.

    Blagg, C. R. The early historical past of dialysis for power renal failure in the USA: a view from Seattle. Am. J. Kidney Dis. 49, 482–496 (2007).

    PubMed 

    Google Scholar 

  • 4.

    Scribner, B. H. Moral issues of utilizing synthetic organs to maintain human life. Trans. Am. Soc. Artif. Intern. Organs 10, 209–212 (1964).

    CAS 
    PubMed 

    Google Scholar 

  • 5.

    Blagg, D. C. R. From Miracle to Mainstream: Creating the World’s First Dialysis Group (Northwest Kidney Facilities, 2017).

  • 6.

    Himmelfarb, J., Berns, A., Szczech, L. & Wesson, D. Price, high quality, and worth: the altering political financial system of dialysis care. J. Am. Soc. Nephrol. 18, 2021–2027 (2007).

    PubMed 

    Google Scholar 

  • 7.

    KDIGO. KDIGO 2012 medical follow guideline for the analysis and administration of power kidney illness. Kidney Int. Suppl. 3, 163 (2013).

    Google Scholar 

  • 8.

    Gap, B. et al. Supportive take care of end-stage kidney illness: an integral a part of kidney providers throughout a variety of revenue settings world wide. Kidney Int. Suppl. 10, e86–e94 (2020).

    Google Scholar 

  • 9.

    Bikbov, B. et al. International, regional, and nationwide burden of power kidney illness, 1990–2017: a scientific evaluation for the International Burden of Illness Research 2017. Lancet 395, 709–733 (2020).

    Google Scholar 

  • 10.

    Liyanage, T. et al. Worldwide entry to therapy for end-stage kidney illness: a scientific overview. Lancet 385, 1975–1982 (2015).

    PubMed 

    Google Scholar 

  • 11.

    Tonelli, M. et al. Framework for establishing built-in kidney care packages in low- and middle-income nations. Kidney Int. Suppl. 10, e19–e23 (2020).

    Google Scholar 

  • 12.

    Pecoits-Filho, R. et al. Capturing and monitoring world variations in untreated and handled end-stage kidney illness, kidney substitute remedy modality, and outcomes. Kidney Int. Suppl. 10, e3–e9 (2020).

    Google Scholar 

  • 13.

    Bello A. Ok. L. et al. International Kidney Well being Atlas: a report by the Worldwide Society of Nephrology on the present state of group and constructions for kidney care throughout the globe. https://www.kidneycareuk.org/paperwork/52/ISN_Global_kidney_health_atlas.pdf (2017).

  • 14.

    White, S. et al. How can we obtain world fairness in provision of renal substitute remedy? Bull. World Well being Organ. 86, 229–237 (2008).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 15.

    Bello, A. Ok. et al. Standing of take care of finish stage kidney illness in nations and areas worldwide: worldwide cross sectional survey. BMJ 367, l5873 (2019).

    PubMed 

    Google Scholar 

  • 16.

    Luxardo, R. et al. The epidemiology of renal substitute remedy in two completely different elements of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Affiliation-European Dialysis and Transplant Affiliation Registry. Rev. Panam. Salud Publica 42, e87 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 17.

    United States Renal Knowledge System. Quantity 2: ESRD in the USA https://www.usrds.org/2018/obtain/2018_Volume_2_ESRD_in_the_US.pdf (2018).

  • 18.

    Jha, V. et al. The state of nephrology in South Asia. Kidney Int. 95, 31–37 (2019).

    PubMed 

    Google Scholar 

  • 19.

    Barsoum, R. S., Khalil, S. S. & Arogundade, F. A. Fifty years of dialysis in Africa: challenges and progress. Am. J. Kidney Dis. 65, 502–512 (2015).

    PubMed 

    Google Scholar 

  • 20.

    Bello, A. Ok. et al. Evaluation of International Kidney Well being Care Standing. JAMA 317, 1864–1881 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 21.

    Fresenius Medical Care. Annual Report 2018: Care and Stay. https://www.freseniusmedicalcare.com/fileadmin/information/com/pdf/Media_Center/Publications/Annual_Reports/FME_Annual-Report_2018.pdf (2018).

  • 22.

    United States Renal Knowledge System. US Renal Knowledge System 2019 Annual Knowledge Report: epidemiology of kidney illness in the USA. https://www.usrds.org/2019/view/USRDS_2019_ES_final.pdf (2019).

  • 23.

    Liu, F. X. et al. A world overview of the affect of peritoneal dialysis first or favored insurance policies: an opinion. Perit. Dial. Int. 35, 406–420 (2015).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 24.

    Mehrotra, R. et al. Racial and ethnic disparities in use of and outcomes with dwelling dialysis in the USA. J. Am. Soc. Nephrol. 27, 2123–2134 (2016).

    PubMed 

    Google Scholar 

  • 25.

    Li, P. Ok.-T. et al. Adjustments within the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13, 90–103 (2017).

    CAS 
    PubMed 

    Google Scholar 

  • 26.

    ANZDATA Registry. ANZDATA Forty second Annual Report 2019. https://www.anzdata.org.au/report/anzdata-Forty second-annual-report-2019/ (2019).

  • 27.

    Kramer, A. et al. The European Renal Affiliation – European Dialysis and Transplant Affiliation (ERA-EDTA) Registry annual report 2015: a abstract. Clin. Kidney J. 11, 108–122 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 28.

    Anand, S., Bitton, A. & Gaziano, T. The hole between estimated incidence of end-stage renal illness and use of remedy. PLoS ONE 8, e72860 (2013).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 29.

    Modi, G. Ok. & Jha, V. The incidence of end-stage renal illness in India: a population-based research. Kidney Int. 70, 2131–2133 (2006).

    CAS 
    PubMed 

    Google Scholar 

  • 30.

    Robinson, B. M. et al. Components affecting outcomes in sufferers reaching end-stage kidney illness worldwide: variations in entry to renal substitute remedy, modality use, and haemodialysis practices. Lancet 388, 294–306 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 31.

    Antlanger, M. et al. Intercourse variations in kidney substitute remedy initiation and upkeep. Clin. J. Am. Soc. Nephrol. 14, 1616 (2019).

    PubMed 

    Google Scholar 

  • 32.

    Chan, Ok. E. et al. Early outcomes amongst these initiating power dialysis in the USA. Clin. J. Am. Soc. Nephro 6, 2642–2649 (2011).

    CAS 

    Google Scholar 

  • 33.

    Thamer, M. et al. Predicting early loss of life amongst aged dialysis sufferers: improvement and validation of a danger rating to help shared determination making for dialysis initiation. Am. J. Kidney Dis. 66, 1024–1032 (2015).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 34.

    Garcia-Garcia, G. et al. Survival amongst sufferers with kidney failure in Jalisco, Mexico. J. Am. Soc. Nephrol. 18, 1922–1927 (2007).

    PubMed 

    Google Scholar 

  • 35.

    Foster, B. J., Mitsnefes, M. M., Dahhou, M., Zhang, X. & Laskin, B. L. Adjustments in extra mortality from finish stage renal illness in the USA from 1995 to 2013. Clin. J. Am. Soc. Nephrol. 13, 91–99 (2018).

    PubMed 

    Google Scholar 

  • 36.

    Storey, B. C. et al. Declining comorbidity-adjusted mortality charges in English sufferers receiving upkeep renal substitute remedy. Kidney Int. 93, 1165–1174 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 37.

    Fenton, S. S. et al. Hemodialysis versus peritoneal dialysis: a comparability of adjusted mortality charges. Am. J. Kidney Dis. 30, 334–342 (1997).

    CAS 
    PubMed 

    Google Scholar 

  • 38.

    Vonesh, E. F., Snyder, J. J., Foley, R. N. & Collins, A. J. The differential affect of danger components on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 66, 2389–2401 (2004).

    PubMed 

    Google Scholar 

  • 39.

    Mehrotra, R., Chiu, Y. W., Kalantar-Zadeh, Ok., Bargman, J. & Vonesh, E. Related outcomes with hemodialysis and peritoneal dialysis in sufferers with end-stage renal illness. Arch. Intern. Med. 171, 110–118 (2011).

    PubMed 

    Google Scholar 

  • 40.

    Mehrotra, R., Devuyst, O., Davies, S. J. & Johnson, D. W. The present state of peritoneal dialysis. J. Am. Soc. Nephrol. 27, 3238–3252 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 41.

    Mehrotra, R. et al. Continual peritoneal dialysis in the USA: declining utilization regardless of bettering outcomes. J. Am. Soc. Nephrol. 18, 2781–2788 (2007).

    PubMed 

    Google Scholar 

  • 42.

    Modi, Z. J. et al. Danger of heart problems and mortality in younger adults with end-stage renal illness: an evaluation of the us renal information system. JAMA Cardiol. 4, 353–362 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 43.

    Wetmore, J. B. et al. Insights from the 2016 peer kidney care initiative report: nonetheless a methods to go to enhance take care of dialysis sufferers. Am. J. Kidney Dis. 71, 123–132 (2018).

    PubMed 

    Google Scholar 

  • 44.

    Skov Dalgaard, L. et al. Danger and prognosis of bloodstream infections amongst sufferers on power hemodialysis: a population-based cohort research. PLoS One 10, e0124547 (2015).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 45.

    Nelveg-Kristensen, Ok. E., Laier, G. H. & Heaf, J. G. Danger of loss of life after first-time blood stream an infection in incident dialysis sufferers with particular consideration on vascular entry and comorbidity. BMC Infect. Dis. 18, 688 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 46.

    Chaudry, M. S. et al. Danger of infective endocarditis in sufferers with finish stage renal illness. Clin. J. Am. Soc. Nephrol. 12, 1814–1822 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 47.

    Pruthi, R., Steenkamp, R. & Feest, T. UK renal registry sixteenth annual report: chapter 8 survival and explanation for loss of life of UK grownup sufferers on renal substitute remedy in 2012: nationwide and centre-specific analyses. Nephron. Clin. Pract. 125, 139–169 (2013).

    PubMed 

    Google Scholar 

  • 48.

    Kucirka, L. M. et al. Affiliation of race and age with survival amongst sufferers present process dialysis. JAMA 306, 620–626 (2011).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 49.

    van den Beukel, T. O. et al. The function of psychosocial components in ethnic variations in survival on dialysis in The Netherlands. Nephrol. Dial. Transpl. 27, 2472–2479 (2012).

    Google Scholar 

  • 50.

    Depner, T. et al. Dialysis dose and the impact of gender and physique dimension on end result within the HEMO research. Kidney Ing. 65, 1386–1394 (2004).

    Google Scholar 

  • 51.

    Villar, E., Remontet, L., Labeeuw, M. & Ecochard, R. Impact of age, gender, and diabetes on extra loss of life in end-stage renal failure. J. Am. Soc. Nephrol. 18, 2125–2134 (2007).

    PubMed 

    Google Scholar 

  • 52.

    Hecking, M. et al. Intercourse-specific variations in hemodialysis prevalence and practices and the male-to-female mortality charge: the dialysis outcomes and follow patterns research (DOPPS). PLoS Med. 11, e1001750 (2014).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 53.

    Erickson, Ok. F., Zhao, B., Ho, V. & Winkelmayer, W. C. Employment amongst sufferers beginning dialysis in the USA. Clin. J. Am. Soc. Nephrol. 13, 265–273 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 54.

    Kurella Tamura, M. et al. Practical standing of aged adults earlier than and after initiation of dialysis. N. Eng. J. Med. 361, 1539–1547 (2009).

    Google Scholar 

  • 55.

    Daratha, Ok. B. et al. Dangers of subsequent hospitalization and loss of life in sufferers with kidney illness. Clin. J. Am. Soc. Nephrol. 7, 409–416 (2012).

    PubMed 

    Google Scholar 

  • 56.

    Davison, S. N. & Jhangri, G. S. Influence of ache and symptom burden on the health-related high quality of lifetime of hemodialysis sufferers. J. Ache. Symptom Handle. 39, 477–485 (2010).

    PubMed 

    Google Scholar 

  • 57.

    Eneanya, N. D. et al. Longitudinal patterns of health-related high quality of life and dialysis modality: a nationwide cohort research. BMC Nephrol. 20, 7 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 58.

    Ju, A. et al. Affected person-reported end result measures for fatigue in sufferers on hemodialysis: a scientific overview. Am. J. Kidney Dis. 71, 327–343 (2018).

    PubMed 

    Google Scholar 

  • 59.

    Rhee, E. P. et al. Prevalence and persistence of uremic signs in incident dialysis sufferers. Kidney360 1, 86–92 (2020).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 60.

    Kimmel, P. L. & Peterson, R. A. Melancholy in sufferers with end-stage renal illness handled with dialysis: has the time to deal with arrived? Clin. J. Am. Soc. Nephrol. 1, 349–352 (2006).

    PubMed 

    Google Scholar 

  • 61.

    Burnier, M., Pruijm, M., Wuerzner, G. & Santschi, V. Drug adherence in power kidney illnesses and dialysis. Nephrol. Dial. Transpl. 30, 39–44 (2015).

    CAS 

    Google Scholar 

  • 62.

    Viecelli, A. Ok. et al. Figuring out critically essential vascular entry outcomes for trials in haemodialysis: a world survey with sufferers, caregivers and well being professionals. Nephrol. Dial. Transpl. 35, 657–668 (2020).

    Google Scholar 

  • 63.

    Ceretta, M. L. et al. Adjustments in co-morbidity sample in sufferers beginning renal substitute remedy in Europe-data from the ERA-EDTA registry. Nephrol. Dial. Transpl. 33, 1794–1804 (2018).

    CAS 

    Google Scholar 

  • 64.

    Vanholder, R. et al. Reimbursement of dialysis: a comparability of seven nations. J. Am. Soc. Nephrol. 23, 1291–1298 (2012).

    PubMed 

    Google Scholar 

  • 65.

    Winkelmayer, W. C., Weinstein, M. C., Mittleman, M. A., Glynn, R. J. & Pliskin, J. S. Well being financial evaluations: the particular case of end-stage renal illness therapy. Med. Decis. Mak. 22, 417–430 (2002).

    Google Scholar 

  • 66.

    Vanholder, R. et al. Lowering the prices of power kidney illness whereas delivering high quality well being care: a name to motion. Nat. Rev. Nephrol. 13, 393–409 (2017).

    PubMed 

    Google Scholar 

  • 67.

    Klarenbach, S. & Manns, B. Financial analysis of dialysis therapies. Semin. Nephrol. 29, 524–532 (2009).

    PubMed 

    Google Scholar 

  • 68.

    van der Tol, A., Lameire, N., Morton, R. L., Van Biesen, W. & Vanholder, R. A global evaluation of dialysis providers reimbursement. Clin. J. Am. Soc. Nephrol. 14, 84–93 (2019).

    PubMed 

    Google Scholar 

  • 69.

    Beaudry, A. et al. Price of dialysis remedy by modality in Manitoba. Clin. J. Am. Soc. Nephrol. 13, 1197–1203 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 70.

    Golper, T. A. The potential affect of the US potential fee system (“bundle”) on the expansion of peritoneal dialysis. Perit. Dial. Int. 33, 596–599 (2013).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 71.

    Lin, E. et al. Dwelling dialysis within the potential fee system period. J. Am. Soc. Nephrol. 28, 2993–3004 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 72.

    Shen, J. I. et al. Expanded potential fee system and use of and outcomes with dwelling dialysis by race and ethnicity in the USA. Clin. J. Am. Soc. Nephrol. 14, 1200–1212 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 73.

    Wang, V. et al. Medicare’s new potential fee system on facility provision of peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 13, 1833–1841 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 74.

    Swanepoel, C. R., Wearne, N. & Okpechi, I. G. Nephrology in Africa–not but uhuru. Nat. Rev. Nephrol. 9, 610–622 (2013).

    PubMed 

    Google Scholar 

  • 75.

    Wang, V., Vilme, H., Maciejewski, M. L. & Boulware, L. E. The financial burden of power kidney illness and end-stage renal illness. Semin. Nephrol. 36, 319–330 (2016).

    PubMed 

    Google Scholar 

  • 76.

    Martin, D. E. et al. A name for skilled collaboration to deal with moral challenges in nephrology. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-0295-4 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 77.

    Harris, D. C. H. et al. Rising entry to built-in ESKD care as a part of common well being protection. Kidney Int. 95, S1–S33 (2019).

    PubMed 

    Google Scholar 

  • 78.

    Rodriguez, R. A. Dialysis for undocumented immigrants in the USA. Adv. Continual Kidney Dis. 22, 60–65 (2015).

    PubMed 

    Google Scholar 

  • 79.

    Saunders, M. R., Lee, H., Maene, C., Schuble, T. & Cagney, Ok. A. Proximity doesn’t equal entry: racial disparities in entry to prime quality dialysis services. J. Racial Ethn. Well being Disparities 1, 291–299 (2014).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 80.

    Shaikh, M. et al. Utilization, prices, and outcomes for sufferers receiving publicly funded hemodialysis in India. Kidney Int. 94, 440–445 (2018).

    PubMed 

    Google Scholar 

  • 81.

    Ladin, Ok. & Smith, A. Ok. Energetic medical administration for sufferers with superior kidney illness. JAMA Intern. Med. 179, 313–315 (2019).

    PubMed 

    Google Scholar 

  • 82.

    Boulware, L. E., Wang, V. & Powe, N. R. Bettering entry to kidney transplantation: enterprise as regular or new methods of doing enterprise? JAMA 322, 931–933 (2019).

    PubMed 

    Google Scholar 

  • 83.

    Van Biesen, W., van der Veer, S. N., Murphey, M., Loblova, O. & Davies, S. Sufferers’ perceptions of knowledge and training for renal substitute remedy: an impartial survey by the European Kidney Sufferers’ Federation on data and help on renal substitute remedy. PLoS ONE 9, e103914 (2014).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 84.

    Mehrotra, R., Marsh, D., Vonesh, E., Peters, V. & Nissenson, A. Affected person training and entry of ESRD sufferers to renal substitute therapies past in-center hemodialysis. Kidney Int. 68, 378–390 (2005).

    PubMed 

    Google Scholar 

  • 85.

    Taylor, D. M. et al. A scientific overview of the prevalence and associations of restricted well being literacy in CKD. Clin. J. Am. Soc. Nephrol. 12, 1070–1084 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 86.

    Vanholder, R., Van Biesen, W. & Lameire, N. Renal substitute remedy: how can we comprise the prices? Lancet 383, 1783–1785 (2014).

    PubMed 

    Google Scholar 

  • 87.

    Moss, A. H. Revised dialysis medical follow guideline promotes extra knowledgeable decision-making. Clin. J. Am. Soc. Nephrol. 5, 2380–2383 (2010).

    PubMed 

    Google Scholar 

  • 88.

    Williams, A. W. et al. Essential and sincere conversations: the proof behind the “Selecting Properly” marketing campaign suggestions by the American Society of Nephrology. Clin. J. Am. Soc. Nephrol. 7, 1664–1672 (2012).

    PubMed 

    Google Scholar 

  • 89.

    Rinehart, A. Past the futility argument: the truthful course of strategy and time-limited trials for managing dialysis battle. Clin. J. Am. Soc. Nephrol. 8, 2000–2006 (2013).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 90.

    Ladin, Ok. et al. Characterizing approaches to dialysis determination making with older adults: a qualitative research of nephrologists. Clin. J. Am. Soc. Nephrol. 13, 1188–1196 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 91.

    Luyckx, V. A. et al. Growing the moral framework of end-stage kidney illness care: from follow to coverage. Kidney Int. Suppl. 10, e72–e77 (2020).

    Google Scholar 

  • 92.

    Davison, S. N., Jhangri, G. S. & Johnson, J. A. Cross-sectional validity of a modified Edmonton symptom evaluation system in dialysis sufferers: a easy evaluation of symptom burden. Kidney Int. 69, 1621–1625 (2006).

    CAS 
    PubMed 

    Google Scholar 

  • 93.

    Weisbord, S. D. et al. Renal supplier recognition of signs in sufferers on upkeep hemodialysis. Clin. J. Am. Soc. Nephrol. 2, 960–967 (2007).

    PubMed 

    Google Scholar 

  • 94.

    Eknoyan, G. et al. Impact of dialysis dose and membrane flux in upkeep hemodialysis. N. Engl. J. Med. 347, 2010–2019 (2002).

    PubMed 

    Google Scholar 

  • 95.

    Paniagua, R. et al. Results of elevated peritoneal clearances on mortality charges in peritoneal dialysis: ADEMEX, a potential, randomized, managed trial. J. Am. Soc. Nephrol. 13, 1307–1320 (2002).

    CAS 
    PubMed 

    Google Scholar 

  • 96.

    Locatelli, F. et al. Impact of membrane permeability on survival of hemodialysis sufferers. J. Am. Soc. Nephrol. 20, 645–654 (2009).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 97.

    Group, F. H. N. T. et al. In-center hemodialysis six occasions per week versus thrice per week. N. Engl. J. Med. 363, 2287–2300 (2010).

    Google Scholar 

  • 98.

    Rocco, M. V. et al. The results of frequent nocturnal dwelling hemodialysis: the frequent hemodialysis community nocturnal trial. Kidney Int. 80, 1080–1091 (2011).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 99.

    Grooteman, M. P. C. et al. Impact of on-line hemodiafiltration on all-cause mortality and cardiovascular outcomes. J. Am. Soc. Nephrol. 23, 1087 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 100.

    Farrington, Ok. & Davenport, A. The ESHOL research: hemodiafiltration improves survival – however how? Kidney Int. 83, 979–981 (2013).

    PubMed 

    Google Scholar 

  • 101.

    Maduell, F. et al. Excessive-efficiency postdilution on-line hemodiafiltration reduces all-cause mortality in hemodialysis sufferers. J. Am. Soc. Nephrol. 24, 487 (2013).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 102.

    Besarab, A. et al. The results of regular as in contrast with low hematocrit values in sufferers with cardiac illness who’re receiving hemodialysis and epoetin. N. Engl. J. Med. 339, 584–590 (1998).

    CAS 
    PubMed 

    Google Scholar 

  • 103.

    Suki, W. N. et al. Results of sevelamer and calcium-based phosphate binders on mortality in hemodialysis sufferers. Kidney Int. 72, 1130–1137 (2007).

    CAS 
    PubMed 

    Google Scholar 

  • 104.

    Wanner, C. et al. Atorvastatin in sufferers with sort 2 diabetes mellitus present process hemodialysis. N. Engl. J. Med. 353, 238–248 (2005).

    CAS 
    PubMed 

    Google Scholar 

  • 105.

    Fellstrom, B. C. et al. Rosuvastatin and cardiovascular occasions in sufferers present process hemodialysis. N. Engl. J. Med. 360, 1395–1407 (2009).

    CAS 
    PubMed 

    Google Scholar 

  • 106.

    Baigent, C. et al. The results of reducing LDL ldl cholesterol with simvastatin plus ezetimibe in sufferers with power kidney illness (Research of Coronary heart and Renal Safety): a randomised placebo-controlled trial. Lancet 377, 2181–2192 (2011).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 107.

    Abdel-Kader, Ok., Unruh, M. L. & Weisbord, S. D. Symptom burden, melancholy, and high quality of life in power and end-stage kidney illness. Clin. J. Am. Soc. Nephrol. 4, 1057–1064 (2009).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 108.

    Mehrotra, R., Berman, N., Alistwani, A. & Kopple, J. D. Enchancment of dietary standing after initiation of upkeep hemodialysis. Am. J. Kidney Dis. 40, 133–142 (2002).

    PubMed 

    Google Scholar 

  • 109.

    Pupim, L. B. et al. Enchancment in dietary parameters after initiation of power hemodialysis. Am. J. Kidney Dis. 40, 143–151 (2002).

    PubMed 

    Google Scholar 

  • 110.

    Rivara, M. B. et al. Adjustments in symptom burden and bodily efficiency with initiation of dialysis in sufferers with power kidney illness. Hemodial. Int. 19, 147–150 (2015).

    PubMed 

    Google Scholar 

  • 111.

    Flythe, J. E. et al. Symptom prioritization amongst adults receiving in-center hemodialysis: a combined strategies research. Clin. J. Am. Soc. Nephrol. 13, 735–745 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 112.

    Tong, A. et al. Establishing core end result domains in hemodialysis: report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. Am. J. Kidney Dis. 69, 97–107 (2017).

    PubMed 

    Google Scholar 

  • 113.

    Evangelidis, N. et al. Growing a set of core outcomes for trials in hemodialysis: a world Delphi survey. Am. J. Kidney Dis. 70, 464–475 (2017).

    PubMed 

    Google Scholar 

  • 114.

    Urquhart-Secord, R. et al. Affected person and caregiver priorities for outcomes in hemodialysis: a world nominal group approach research. Am. J. Kidney Dis. 68, 444–454 (2016).

    PubMed 

    Google Scholar 

  • 115.

    Manera, Ok. E. et al. Affected person and caregiver priorities for outcomes in peritoneal dialysis: multinational nominal group approach research. Clin. J. Am. Soc. Nephrol. 14, 74–83 (2019).

    PubMed 

    Google Scholar 

  • 116.

    Manera, Ok. E. et al. A global Delphi survey helped develop consensus-based core end result domains for trials in peritoneal dialysis. Kidney Int. 96, 699–710 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 117.

    Duarte, P. S., Miyazaki, M. C., Blay, S. L. & Sesso, R. Cognitive-behavioral group remedy is an efficient therapy for main melancholy in hemodialysis sufferers. Kidney Int. 76, 414–421 (2009).

    PubMed 

    Google Scholar 

  • 118.

    Taraz, M. et al. Sertraline decreases serum stage of interleukin-6 (IL-6) in hemodialysis sufferers with melancholy: outcomes of a randomized double-blind, placebo-controlled medical trial. Int. Immunopharmacol. 17, 917–923 (2013).

    CAS 
    PubMed 

    Google Scholar 

  • 119.

    Cukor, D. et al. Psychosocial intervention improves melancholy, high quality of life, and fluid adherence in hemodialysis. J. Am. Soc. Nephrol. 25, 196–206 (2014).

    CAS 
    PubMed 

    Google Scholar 

  • 120.

    Friedli, Ok. et al. Sertraline versus placebo in sufferers with main depressive dysfunction present process hemodialysis: a randomized, managed feasibility trial. Clin. J. Am. Soc. Nephrol. 12, 280–286 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 121.

    Mehrotra, R. et al. Comparative efficacy of therapies for therapy of melancholy for sufferers present process upkeep hemodialysis: a randomized medical trial. Ann. Intern. Med. 170, 369–379 (2019).

    PubMed 

    Google Scholar 

  • 122.

    Mendu, M. L. et al. Measuring high quality in kidney care: an analysis of current high quality metrics and strategy to facilitating enhancements in care supply. J. Am. Soc. Nephrol. 31, 602–614 (2020).

    PubMed 

    Google Scholar 

  • 123.

    Nair, D. & Wilson, F. P. Affected person-reported end result measures for adults with kidney illness: present measures, ongoing initiatives, and future alternatives for incorporation into patient-centered kidney care. Am. J. Kidney Dis. 74, 791–802 (2019).

    PubMed 

    Google Scholar 

  • 124.

    Himmelfarb, J. & Ratner, B. Wearable synthetic kidney: issues, progress and prospects. Nat. Rev. Nephrol. in press [doi to be supplied]

  • 125.

    Foo, M. W. Y. & Htay, H. Improvements in peritoneal dialysis. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0283-8 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 126.

    Agar, J. W. M. & Barraclough, Ok. A. Water use in dialysis: environmental concerns. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0296-3 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 127.

    Masereeuw, R. & Verhaar, M. C. Improvements in approaches to take away uraemic toxins. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0299-0 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 128.

    Geremia, I. & Stamatialis, D. Improvements in dialysis membranes for improved kidney substitute remedy. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0293-6 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 129.

    Gedney, N., Sipma, W. & Søndergaard, H. Improvements in dialysis: the person’s perspective. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0292-7 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 130.

    Wieringa, F. P., Sheldon, M. I. & Hidalgo-Simon, A. Regulatory approaches to stimulate revolutionary renal substitute therapies. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0275-8 (2020).

    Article 
    PubMed 

    Google Scholar 

  • 131.

    Kidney Well being Initiatve. Fostering Innovation in Fluid Administration. https://khi.asn-online.org/uploads/KHI_InnovationsInFluidManagement.pdf (2019).

  • 132.

    Flythe, J. E. et al. Fostering innovation in symptom administration amongst hemodialysis sufferers. Clin. J. Am. Soc. Nephrol. 14, 150 (2019).

    PubMed 

    Google Scholar 

  • 133.

    Shenoy, S. et al. Scientific trial finish factors for hemodialysis vascular entry. Clin. J. Am. Soc. Nephrol. 13, 490 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 134.

    Dember, L. M. et al. Pragmatic trials in upkeep dialysis: views from the kidney well being initiative. J. Am. Soc. Nephrol. 27, 2955 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 135.

    Canaud, B., Vienken, J., Ash, S. & Ward, R. A. Hemodiafiltration to deal with unmet medical wants ESKD sufferers. Clin. J. Am. Soc. Nephrol. 13, 1435 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 136.

    Trump, D. J. Government Order on Advancing American Kidney Well being. The White Home https://www.whitehouse.gov/presidential-actions/executive-order-advancing-american-kidney-health/ (2019).

  • 137.

    Kidney Well being Initiative. Expertise Roadmap for Revolutionary Approaches to Renal Alternative Remedy. https://www.asn-online.org/g/blast/recordsdata/KHI_RRT_Roadmap1.0_FINAL_102318_web.pdf (2018).

  • 138.

    Tijink, M. S. L. et al. Blended matrix membranes: a brand new asset for blood purification therapies. Blood Purif. 37, 1–3 (2014).

    CAS 
    PubMed 

    Google Scholar 

  • 139.

    Vijayan, A. & Boyce, J. M. 100% use of an infection management procedures in hemodialysis services: name to motion. Clin. J. Am. Soc. Nephrol. 13, 671–673 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 140.

    Wong, L. P. Attaining dialysis security: the crucial function of higher-functioning groups. Semin. Dial. 32, 266–273 (2019).

    PubMed 

    Google Scholar 

  • 141.

    Kliger, A. S. & Collins, A. J. Lengthy overdue want to cut back infections with hemodialysis. Clin. J. Am. Soc. Nephrol. 12, 1728–1729 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 142.

    Kliger, A. S. Concentrating on zero infections in dialysis: new gadgets, sure, but additionally tips, checklists, and a tradition of security. J. Am. Soc. Nephrol. 29, 1083–1084 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 143.

    Collins, A. J. & Kliger, A. S. Pressing: cease preventable infections now. Clin. J. Am. Soc. Nephrol. 13, 663–665 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • 144.

    The George Institute. World’s first inexpensive dialysis machine a finalist in 2017 Eureka Awards. https://www.georgeinstitute.org.au/media-releases/worlds-first-affordable-dialysis-machine-a-finalist-in-2017-eureka-awards (2017).

  • 145.

    Institute for Healthcare Enchancment. A affected person directs his personal care. http://www.ihi.org/assets/Pages/ImprovementStories/APatientDirectsHisOwnCareFarmanSelfDialysis.aspx (2020).

  • 146.

    Shinkman, R. Is “empowered dialysis” the important thing to raised outcomes? NEJM Catalyst Carryover https://doi.org/10.1056/CAT.18.0232 (2018).

    Article 

    Google Scholar 

  • 147.

    Nayak, Ok. S., Ronco, C., Karopadi, A. N. & Rosner, M. H. Telemedicine and distant monitoring: supporting the affected person on peritoneal dialysis. Perit. Dial. Int. 36, 362–366 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 148.

    Rohatgi, R., Ross, M. J. & Majoni, S. W. Telenephrology: present views and future instructions. Kidney Int. 92, 1328–1333 (2017).

    PubMed 

    Google Scholar 

  • 149.

    Lew, S. Q. & Sikka, N. Operationalizing telehealth for dwelling dialysis sufferers in the USA. Am. J. Kidney Dis. 74, 95–100 (2019).

    PubMed 

    Google Scholar 

  • 150.

    Bieber, S. D. & Gadegbeku, C. A. A name to motion for the kidney neighborhood: nephrologists’ perspective on advancing American kidney well being. Clin. J. Am. Soc. Nephrol. 14, 1799–1801 (2019).

    PubMed 

    Google Scholar 

  • 151.

    Basis for EU democracy. Consolidated Reader-Pleasant Version of the Treaty on European Union (TEU) and the Treaty on the Functioning of the European Union (TFEU) as amended by the Treaty of Lisbon (2007) Third version. http://en.euabc.com/add/books/lisbon-treaty-3edition.pdf (2009).

  • 152.

    European Kidney Well being Alliance. Thematic Community on Bettering Organ Donation and Transplantation within the EU 2019. http://ekha.eu/wp-content/uploads/FINAL_Joint-Assertion-of-the-Thematic-Community-on-Organ-Donation-and-Transplantation.pdf (2019).

  • 153.

    Massy, Z. A. et al. Nephrology and public coverage committee propositions to stimulate analysis collaboration in adults and kids in Europe. Nephrol. Dial. Transpl. 34, 1469–1480 (2019).

    Google Scholar 

  • 154.

    Beating kidney illness. A joint agenda for analysis and innovation. https://www.nierstichting.nl/media/filer_public/4d/6d/4d6d6b4e-ce56-4a4b-8ba2-f5ac957d0df8/beating_kidney_disease_-_joint_agenda_for_ri_june_2018.pdf (2018).

  • 155.

    Matesanz, R., Marazuela, R., Coll, E., Mahillo, B. & Dominguez-Gil, B. In regards to the Decide-Out system, dwell transplantation, and data to the general public on organ donation in Spain… Y ole! Am. J. Transpl. 17, 1695–1696 (2017).

    CAS 

    Google Scholar 

  • 156.

    Zivcic-Cosic, S. et al. Growth of the Croatian mannequin of organ donation and transplantation. Croat. Med. J. 54, 65–70 (2013).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Leave a Reply

    Your email address will not be published. Required fields are marked *